Moderna Inc (NYSE:MRNA)


Cambridge-headquartered American biotech company Moderna Inc (NASDAQ:MRNA) is engaged in developing mRNA-based medicines for a broad range of disorders including rare diseases, infectious diseases, cardiovascular disease, and cancers. The Company has manufactured an mRNA vaccine that utilizes genetic material part of SARS-CoV-2 virus to stimulate an immune response from the human body.

Similar Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK